Actin-Binding rho Activating Protein (ABRA) Peptide
ABRA
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all ABRA products
- ABRA (Actin-Binding rho Activating Protein (ABRA))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KEGSKTAERA KRAEEHIYRE IMELCFVIRT MARHRRDGKI QVTFGELFDR
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of Abra antibody,
Alternative Names: Abra control peptide, Abra antibody Blocking Peptide, Anti-Abra Blocking Peptide, actin-binding Rho activating protein Blocking Peptide, C130068O12Rik Blocking Peptide, STARS Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- ABRA (Actin-Binding rho Activating Protein (ABRA))
- Background
- ABRA acts as an activator of serum response factor (SRF)-dependent transcription possibly by inducing nuclear translocation of MKL1 or MKL2 and through a mechanism requiring Rho-actin signaling.
- Molecular Weight
- 41 kDa
-
You are here:
